Lionco Pharm Grp Co Ltd (603669) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.108x

Based on the latest financial reports, Lionco Pharm Grp Co Ltd (603669) has a cash flow conversion efficiency ratio of -0.108x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-79.09 Million ≈ $-11.57 Million USD) by net assets (CN¥735.30 Million ≈ $107.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Lionco Pharm Grp Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Lionco Pharm Grp Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Lionco Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Lionco Pharm Grp Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Lionco Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lionco Pharm Grp Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PTC India Limited NSE:PTC	0.317x
Mühlbauer Holding AG XETRA:MUB	0.114x
Beijing JCZ Technology Co. Ltd. A SHG:688291	N/A
Bénéteau S.A. PA:BEN	0.192x
Tivoli A/S CO:TIV	0.087x
Diversified Royalty Corp TO:DIV	0.043x
First Sensor AG F:SIS	0.047x
Anhui Ronds Science & Technology Inc Co SHG:688768	-0.637x

Annual Cash Flow Conversion Efficiency for Lionco Pharm Grp Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Lionco Pharm Grp Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Lionco Pharm Grp Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥620.28 Million ≈ $90.77 Million	CN¥-132.87 Million ≈ $-19.44 Million	-0.214x	-48.69%
2024-12-31	CN¥769.76 Million ≈ $112.64 Million	CN¥-110.89 Million ≈ $-16.23 Million	-0.144x	-254.12%
2023-12-31	CN¥931.04 Million ≈ $136.24 Million	CN¥-37.87 Million ≈ $-5.54 Million	-0.041x	+30.41%
2022-12-31	CN¥1.14 Billion ≈ $166.11 Million	CN¥-66.36 Million ≈ $-9.71 Million	-0.058x	-166.36%
2021-12-31	CN¥1.46 Billion ≈ $213.47 Million	CN¥128.50 Million ≈ $18.80 Million	0.088x	+2.79%
2020-12-31	CN¥1.48 Billion ≈ $216.55 Million	CN¥126.81 Million ≈ $18.56 Million	0.086x	-52.21%
2019-12-31	CN¥1.31 Billion ≈ $192.25 Million	CN¥235.61 Million ≈ $34.48 Million	0.179x	+32.94%
2018-12-31	CN¥1.38 Billion ≈ $201.64 Million	CN¥185.87 Million ≈ $27.20 Million	0.135x	-7.27%
2017-12-31	CN¥1.30 Billion ≈ $190.12 Million	CN¥189.01 Million ≈ $27.66 Million	0.145x	-6.66%
2016-12-31	CN¥1.17 Billion ≈ $171.13 Million	CN¥182.27 Million ≈ $26.67 Million	0.156x	+76.47%
2015-12-31	CN¥1.12 Billion ≈ $163.82 Million	CN¥98.88 Million ≈ $14.47 Million	0.088x	-81.79%
2014-12-31	CN¥374.13 Million ≈ $54.75 Million	CN¥181.50 Million ≈ $26.56 Million	0.485x	+5.92%
2013-12-31	CN¥351.02 Million ≈ $51.37 Million	CN¥160.77 Million ≈ $23.53 Million	0.458x	-24.13%
2012-12-31	CN¥236.22 Million ≈ $34.57 Million	CN¥142.61 Million ≈ $20.87 Million	0.604x	-20.99%
2011-12-31	CN¥128.55 Million ≈ $18.81 Million	CN¥98.23 Million ≈ $14.37 Million	0.764x	--

About Lionco Pharm Grp Co Ltd

SHG:603669 China Drug Manufacturers - Specialty & Generic

Market Cap

$561.83 Million

CN¥3.84 Billion CNY

Market Cap Rank

#11448 Global

#3174 in China

Share Price

CN¥5.39

Change (1 day)

+6.94%

52-Week Range

CN¥4.05 - CN¥8.11

All Time High

CN¥12.67